PIK3CB and thyroid cancer: Using mESC-derived thyroid cancer organoids, Lasolle et al. showed that combined MAPK and PI3K inhibition reverses BRAFV637E-induced dedifferentiation in mouse cells and restores thyroid follicular structure and function in vitro [84].